All articles tagged with #uk healthcare
NHS England is rolling out Martha's Rule to every A&E department in the country. This safety measure allows patients, families, and staff to trigger urgent reviews of care if they fear a patient is deteriorating. The expansion follows a successful pilot and aims to prevent preventable deaths, with full implementation targeted for March 2028.
Hypermobility Spectrum Disorder (HSD) and hypermobile Ehlers-Danlos Syndrome (hEDS) are connective tissue conditions causing joint instability, fatigue, and pain. New research indicates that hundreds of thousands of UK residents may be affected, yet many endure diagnostic delays averaging 19 to 21.7 years. The lack of a dedicated clinical guideline from the National Institute for Health and Care Excellence (NICE) contributes to inconsistent care. Patients often rely on social media for information due to limited access to knowledgeable clinicians, with only 13% reporting such access. Symptoms can worsen after stressors like puberty or menopause, and while physiotherapy helps, there is no single cure. Experts urge better government recognition and coordinated care to address the condition's impact on work and daily life.
A 14-year-old girl from Yorkshire, England, has spoken out after being repeatedly dismissed by doctors who claimed she was too young to have endometriosis. Grace began experiencing severe, stabbing pain at age 13, which she initially mistook for a ruptured appendix. Despite multiple emergency room visits and a family history of the condition, she was denied a gynecologist referral and prescribed the contraceptive pill without relief. A private consultation initially attributed her symptoms to mental health and ADHD, but a subsequent laparoscopy in June confirmed endometriosis on her uterus and ligaments. Grace is now using social media to advocate for young patients and encourage self-advocacy in medical settings.
Jade Fardon, a 33-year-old non-smoker from Watford, England, was diagnosed with stage 4 ALK-positive lung cancer in 2022 after years of dismissed coughs. Initially attributed to COVID-19, her symptoms persisted, leading to a CT scan that revealed extensive tumors in both lungs. She underwent targeted oral therapy, which initially controlled the disease, but brain metastases emerged in 2023. Despite gamma knife radiation and surgery, the cancer progressed, requiring new medication. Fardon now works part-time while raising awareness for ALK-positive patients.
A YouGov poll of over 20,000 psychiatrists shows about 75% of UK women don’t know menopause can trigger a new mental illness, leading the Royal College of Psychiatrists to publish a position statement urging better awareness, training, and policy action. The report notes perimenopause doubles the risk of bipolar disorder and increases clinical depression risk, with associated misdiagnosis and anxiety; it also highlights gaps in care, calls for workforce and workplace support, NHS investment, and more research. Personal stories underscore diagnostic delays and the impact on women’s mental health.
A UK doctor was suspended for five months after scheduling fake appointments to leave work early and pick up her children, sparking debate about the pressures faced by working parents and the need for reforms in the healthcare system.
Health Secretary Wes Streeting has approved a clinical trial for puberty blockers in children with gender dysphoria, despite personal discomfort and opposition from some politicians, following recommendations from the Cass Review to better research the drugs' effects.
Prime Minister Keir Starmer criticized the ongoing five-day strike by NHS resident doctors in England, calling it 'dangerous' and urging doctors to prioritize patient care. The strike, driven by demands for better pay and training opportunities, has led to significant disruptions in NHS services amid a surge in winter illnesses. The government and union remain at an impasse, with concerns about the impact on patient safety and NHS operations during the holiday season.
The MHRA in the UK is planning major reforms to accelerate the development, testing, and approval of rare disease therapies, aiming to overcome current barriers and make treatments more accessible, supported by a new framework and collaborative efforts to position the UK as a global leader in rare disease innovation.
In a UK first, patients with sleep apnoea have been fitted with a new app-controlled implant that stimulates tongue nerves to aid breathing during sleep. The Genio implant, developed by Nyxoah, was successfully implanted in two patients at University College London Hospitals. This device offers an alternative to CPAP machines, which can be uncomfortable for some users. The implant is controlled by an external chip and can be adjusted via a smartphone app. This development marks a significant advancement in treatment options for sleep apnoea patients in the UK.
Four years into the Covid pandemic, long Covid continues to disproportionately affect poorer communities, frontline workers, and those with pre-existing health conditions, exacerbating existing inequalities. Despite the Labour government's promises to address these issues, their plans lack clarity and sufficient funding, particularly for long Covid services and workplace protections. The NHS remains under strain, and advocacy groups are stepping in to fill gaps left by government inaction. The situation highlights the urgent need for bold, decisive action to address the systemic inequalities worsened by long Covid.
A cancer charity is advocating for prostate cancer screening for high-risk men aged 45 and over, citing economic benefits despite the lack of a national screening program in the UK. The current PSA test is criticized for its inaccuracy, as it can lead to overdiagnosis and unnecessary treatment of slow-growing cancers. While some experts argue for targeted screening, especially for black men and those with a family history, others highlight the psychological and physical harms of over-treatment. Ongoing research aims to improve screening methods, but results are years away.
A shortage of nuclear isotopes in the UK is causing delays in cancer diagnoses, potentially leading to increased cancer deaths. Experts are urging the UK to develop its own isotope production facility, such as the proposed Project Arthur in Wales, to reduce reliance on imports. The shortage follows a halt in production at a Dutch reactor, highlighting the urgent need for a domestic supply to prevent future shortages and save lives.